A--Drug Manufacturing and Formulation Program (DMFP)
Posted Date:
May 05, 2026
May 19, 2026
Awarded Date:
May 04, 2026
| SetAside Type | ||
| No Set aside used | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00077 | A--Drug Manufacturing and Formulation Program (DMFP) | |
| Synopsis | ||
|
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00. .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00077 | A--Drug Manufacturing and Formulation Program (DMFP) | |
| Synopsis | ||
|
A--Drug Manufacturing and Formulation Program (DMFP) .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00077 | A--Drug Manufacturing and Formulation Program (DMFP) | |
| Synopsis | ||
|
Drug Manufacturing and Formulation Program (DMFP)
THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. A REQUEST FOR PROPOSALS (RFP) NO. 75N95024R00077, ENTITLED: "NINDS Drug Manufacturing and Formulation Program (DMFP)" WILL BE ISSUED FOR FULL AND OPEN COMPETITION VIA www.SAM.gov ON OR ABOUT May 24, 2024. The National Institutes of Neurological Disorders and Stroke (NINDS) has a continued need for compound formulation and manufacturing services to support the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network (BPN). The goal of this DMFP requirement is to initiate and complete active pharmaceutical .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00077 | A--Drug Manufacturing and Formulation Program (DMFP) | |
| Synopsis | ||
|
A--Drug Manufacturing and Formulation Program (DMFP) .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N95024R00077 | A--Drug Manufacturing and Formulation Program (DMFP) | |
| Synopsis | ||
|
Drug Manufacturing and Formulation Program (DMFP)
THIS IS NOT A REQUEST FOR PROPOSALS (RFP). THIS IS A PRE-SOLICITATION ANNOUNCEMENT ONLY. A REQUEST FOR PROPOSALS (RFP) NO. 75N95024R00077, ENTITLED: "NINDS Drug Manufacturing and Formulation Program (DMFP)" WILL BE ISSUED FOR FULL AND OPEN COMPETITION VIA www.SAM.gov ON OR ABOUT May 20, 2024. The National Institutes of Neurological Disorders and Stroke (NINDS) has a continued need for compound formulation and manufacturing services to support the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network (BPN). The goal of this DMFP requirement is to initiate and complete active pharmaceutical .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
